Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million

"This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future"

24-May-2024 - Merck has signed a definitive agreement to acquire life science company Mirus Bio for US$600million (around €550million). Based in Madison, Wisconsin, USA, Mirus Bio is a specialist in the development and commercialization of transfection reagents. Transfection reagents, such as Mirus Bio's ...

Bio-Techne announces new distribution agreement with Thermo Fisher Scientific

07-May-2024 - Bio-Techne Corporation to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific in Europe. This partnership marks an important ...

Danaher to Acquire Abcam

30-Aug-2023 - Danaher Corporation announced that it has entered into a definitive agreement to acquire Abcam plc, a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash, or a total enterprise value of ...

Sartorius acquires French provider of innovative upstream technologies for cell and gene therapies

Agreed purchase price of approximately 2.4 billion euros

03-Apr-2023 - The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has signed an agreement to acquire Polyplus for approximately 2.4 billion euros from private investors including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg Pincus. Polyplus, with ...

QIAGEN acquires majority stake in enzymes provider BLIRT S.A.

BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents

12-May-2022 - QIAGEN N.V. announced that it has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A., a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland. BLIRT develops, manufactures and commercializes standardized and customized solutions for ...

Sartorius acquires majority stake in CellGenix

Portfolio expanded by cell culture components, such as growth factors, cytokines, and media

05-Jul-2021 - The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the biotechnology hub in Boston, Massachusetts USA, produces and ...

Successful exit – Proteintech acquires ChromoTek

The acquisition enables Proteintech to expand its next-generation antibody tools

21-Oct-2020 - High-Tech Gründerfonds and Bayern Kapital have sold their shares in ChromoTek after having spent 10 years at the start-up’s side. ChromoTek is the market leader in nanobodies — high-performance recombinant reagents that are used for breakthrough research discoveries. The combined companies will ...

New Digital Marketplace for Life Science Products

Customer-centric, science-driven platform opens market with scientifically informed purchasing

13-Dec-2018 - Labviva, an AI-powereddigital marketplace for life sciencereagents, instrumentation and servicesannounces today its launch to create scientifically informed purchasing decisions. “We recognize the critical need toconnect buyers and suppliers of scientific products in a new way, with ...

Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

12-Jul-2018 - Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gyrolab® ...

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

23-Sep-2014 - Merck and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outstanding ...